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Abstract
Background: The processing ability of poultry meat is highly related to its ultimate pH, the latter being mainly
determined by the amount of glycogen in the muscle at death. The genetic determinism of glycogen and related
meat quality traits has been established in the chicken but the molecular mechanisms involved in variations in
these traits remain to be fully described. In this study, Chicken Genome Arrays (20 K) were used to compare
muscle gene expression profiles of chickens from Fat (F) and Lean (L) lines that exhibited high and low muscle
glycogen content, respectively, and of individuals exhibiting extremely high (G+) or low (G-) muscle glycogen
content originating from the F2 cross between the Fat and Lean lines. Real-time RT-PCR was subsequently
performed to validate the differential expression of genes either selected from the microarray analysis or whose
function in regulating glycogen metabolism was well known.
Results: Among the genes found to be expressed in chicken P. major muscle, 197 and 254 transcripts appeared to
be differentially expressed on microarrays for the F vs. L and the G+ vs. G- comparisons, respectively. Some
involved particularly in lipid and carbohydrate metabolism were selected for further validation studies by real-time
RT-PCR. We confirmed that, as in mammals, the down-regulation of CEBPB and RGS2 coincides with a decrease in
peripheral adiposity in the chicken, but these genes are also suggested to affect muscle glycogen turnover
through their role in the cAMP-dependent signalling pathway. Several other genes were suggested to have roles
in the regulation of glycogen storage in chicken muscle. PDK4 may act as a glycogen sensor in muscle, UGDH may
compete for glycogen synthesis by using UDP-glucose for glucoronidation, and PRKAB1, PRKAG2, and PHKD may
impact on glycogen turnover in muscle, through AMP-activated signalling pathways.
Conclusions: This study is the first stage in the understanding of molecular mechanisms underlying variations in
poultry meat quality. Large scale analyses are now required to validate the role of the genes identified and
ultimately to find molecular markers that can be used for selection or to optimize rearing practices.
Background
With changes similar to those that occurred in the pig
industry, the poultry market is now characterized by
increasing diversity of processed products [1]. As a con-
sequence, poultry companies are now involved in food
technology and product development, and improvement
of meat processing ability has become a prevalent con-
cern. As in pigs, post-mortem pH is a key factor
controlling chicken meat quality [2]. Variations in ulti-
mate meat pH (pHu) are responsible for variations in
several breast meat properties, including water-holding
capacity, colour and firmness [2,3]. Low ultimate pH
results in “acid meat”, with a pale aspect and reduced
water-holding capacity [4], while high ultimate pH leads
to DFD (dark, firm, dry) meat, dark in colour, with
reduced shelf-life [5]. At the genetic level, there is a very
strong negative correlation between the ultimate pH of
breast meat and the level of muscle glycogen estimated
by the glycolytic potential at the time of slaughter (rg
-0.97) [3]. The glycolytic potential has also been shown
* Correspondence: Cecile.Berri@tours.inra.fr
1INRA UR83 Recherches Avicoles, Institut National de la Recherche
Agronomique, F-37380 Nouzilly, France
Full list of author information is available at the end of the article
Sibut et al. BMC Genomics 2011, 12:112
http://www.biomedcentral.com/1471-2164/12/112
© 2011 Sibut et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.to be highly heritable (h
2 0.43) [3]. Understanding the
mechanisms and identifying the genes controlling mus-
cle glycogen storage constitute a promising way to
increase control of and improve chicken breast meat
properties. It would make it possible to develop useful
breeding tools, such as molecular markers, to select
birds with expected meat properties, and help optimize
rearing practices, via the study of gene regulation.
Glycogen is the main metabolic fuel for the anaerobic
glycolysis which takes place post-mortem when muscles
are no longer supplied with oxygen. The genetic control
of muscle glycogen, and therefore meat quality, was evi-
denced first in mammals and more recently in the
chicken [3]. In mammalian species, including the pig,
mouse and human, a major gene, PRKAG3 which
encodes the g3 regulatory subunit of the AMP-activated
protein kinase (AMPK), is responsible for variations in
muscle glycogen content [6-10]. In the chicken, there is
no information available suggesting that a major gene
could be involved in the control of glycogen content in
muscle. However, several studies have suggested that
breast muscle glycogen content is related to growth and
body composition: it decreases with growth rate and
breast meat yield [2,11] and increases with carcass fat-
ness [12,13].
The aim of the present study was to compare the
expression profiles of muscles from chickens differing in
muscle glycogen content and breast meat quality. In the
first experiment, birds originating from two experimen-
tal lines (i.e. Fat (F) and Lean (L) lines) were compared.
The F and L lines were originally divergently selected
for and against the amount of abdominal fat [14] but
they also exhibited differences in muscle glycogen con-
tent and in breast meat quality traits [13]. Despite a
similar growth rate, the chickens from the F line were 3
times fattier than those from the L line. Moreover, due
to high muscle glycogen content, the meat of the fat
chickens exhibited a lower ultimate pH and higher drip
loss and lightness than lean chickens. The differences in
muscle glycogen between the F and L lines have been
related to variations in mRNA encoding several enzymes
regulating glycogen synthesis and degradation as well as
in activation of AMPK by phosphorylation [13]. In the
second experiment, the muscle transcriptomes were
compared in individuals generated from the F2 popula-
tion produced from these two lines (i.e. F2FL) and exhi-
biting extremely high (G+) or low (G-) muscle glycogen
content. Individuals for this analysis were chosen
according to their levels of glycogen in muscle, while
differences in body fatness were much less pronounced
than in the first model.
The use of a 20 K oligo microarray provided the first
description of genes differentially expressed between
breast muscles exhibiting high or low glycogen content,
correlated with poor or high meat quality traits, respec-
tively. This global approach was complemented by
mRNA analyses on previously studied candidate genes
[13] and on a subset of genes identified from array ana-
lysis. For genes with a human ortholog, further interpre-
tation was based on the use of Ingenuity and Gene
Ontology annotation databases highlighting several bio-
logical processes likely to be involved in muscle glyco-
gen regulation.
Results
Carcass, muscle and meat quality traits of chickens used
for gene expression analyses
The mean carcass and P. major muscle traits and SD are
presented in Table 1. At 9 weeks of age, body weight
was similar between F and L birds and between G+ and
G- birds generated from the F2FL population. Breast
meat yield was slightly higher in L than in F birds and
similar between G+ and G-. Abdominal fat yield was
2-fold greater in F than in L birds while it was only 30%
greater in G+ compared to G- birds. However, the mus-
cle glycogen reserves were 61% higher in G+ than in
G- birds while they were only 34% higher in F than in L
birds. The ultimate pH of P. major muscle of F and G+,
in relation to their greater glycogen content at the time
of death, was higher than that of L and G- birds, respec-
tively. The breast meat was lighter (greater L*) and less
coloured (lower a* and b*), and exhibited more drip loss
in F than in L birds. Only meat lightness (L*) was higher
in G+ than in G- birds generated from the F2FL
population.
Differential analysis on microarray
Among the genes found to be expressed in chicken P.
major muscle, 197 and 254 transcripts were differentially
expressed between F and L and G+ and G-, respectively
(Additional files 1 and 2). T h eg e n ee x p r e s s i o nf o l d -
change ranged from 0.41 to 2.69 and 0.48 to 2.23 for
the F vs. L and the G+ vs. G- comparisons, respectively.
A trend was observed for a higher percentage of genes
down-regulated in muscle with high glycogen content
(57 and 60% in F and G+, respectively). Full details of
gene name, function, accession number, fold-change and
p-value for all differentially expressed transcripts are
listed in additional files 1 and 2. Only 12 transcripts
were recorded as differential in both analyses, i.e. F vs. L
and G+ vs. G-, corresponding to 7 known genes
(Additional file 3).
Functional annotation
Among the genes that were reported to be differentially
expressed between muscles with high or low glycogen
content, 337 with a human ortholog were submitted to
annotation analyses. When compiling the lists of genes
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F and L chickens, the software Ingenuity Analysis Path-
ways 7.0 (IPA, Ingenuity System
®, http://www.ingenuity.
com) highlighted several biological functions (Table 2),
including Lipid and Carbohydrate Metabolism. The
genes associated with these two functions represent
about 15% of the 337 genes considered for annotation
analysis. When considering findings separately, IPA
highlighted lipid metabolism and molecular transport as
common pathways in the two models (G+/G- and F/L)
and also specific biological functions for each of them:
Cell Morphology, Cell Cycle, and Cell to Cell Signalling
and Interaction for F/L, and Small Molecular Biochem-
istry, Cell Death, and Cellular Development for G+/G-.
Gene Ontology (GO) terms are also widely used for glo-
bal interpretation of the functions of genes revealed by
differential microarray analysis. According to Gene
Ontology, genes differentially expressed between F and
L participated in several biological processes that can be
grouped in 4 main biological functions: molecule trans-
port and localization, and lipid, energy, and amino acid
metabolism. Genes differentially expressed between G+
and G- belonged to biological processes especially
related to lipid and energy metabolism, as well as devel-
opmental processes including cell growth, proliferation,
differentiation and organization.
Validation by real-time RT-PCR of a subset of genes
revealed by differential microarray analysis
The mRNA levels of 16 genes involved in Skeletal and
Muscular System Development and Function, Lipid
Metabolism or Carbohydrate Metabolism, and found to
Table 1 Body weights and yields, and Pectoralis major muscle and meat quality traits of animals used for expression
analyses
Fat Lean G+ G-
Chickens (n) 8 8 p value 88 p value
Growth and body composition
Body Weight (g) 1765 ± 99 1679 ± 178 NS 1891 ± 226 1979 ± 195 NS
Breast Yield (%) 12.4 ± 0.7 13.4 ± 0.8 < 0.05 12.0 ± 0.9 12.1 ± 0.7 NS
Abdominal Fat Yield (%) 5.2 ± 0.9 2.6 ± 0.7 < 0.001 3.8 ± 0.7 2.9 ± 0.8 < 0.05
Breast meat quality traits
Glycolytic Potential (μM/g) 122 ± 8 91 ± 4 < 0.001 126 ± 9 78 ± 5 < 0.001
Ultimate pH 5.66 ± 0.06 5.86 ± 0.08 < 0.001 5.55 ± 0.07 5.88 ± 0.07 < 0.001
Lightness (L*) 49.7 ± 2.4 43.96 ± 2.1 < 0.001 50.6 ± 1.4 48.3 ± 1.7 < 0.01
Redness (a*) -0.2 ± 0.6 1.7 ± 0.6 < 0.001 0.2 ± 0.7 0.4 ± 1.6 NS
Yellowness (b*) 11.0 ± 1.8 12.6 ± 0.9 < 0.05 11.2 ± 1.6 11.4 ± 2.0 NS
Drip Loss (%) 1.7 ± 0.7 1.0 ± 0.5 < 0.05 1.2 ± 0.65 1.1 ± 0.67 NS
The G+ and G- chickens were generated from the F2FL population produced from the 2 generation intercross between the founder Fat and Lean lines.
The G- and G+ chickens correspond to the individual females exhibiting the lowest and the highest muscle glycogen content within the F2FL population.
NS = non-significant.
Table 2 Relevant biological functions identified from the annotation analysis
Category P-value Molecules
Lipid Metabolism 9.42E-05-
2.56E-02
ABCA12, ABCA2, ABHD5, ACSBG2, ACSL1, ADF,ADIPOR2, ALDH1A1, AOX1,CD38, CEBPB,CETP, CTSS, DCI,
DRD3,GOT2, GRB10,HMGCL, HTT,INSIG1, LASS4, LPAR1,LPIN1,MTMR6, MTMR7,PCTP, PDK4,PHYH, PIK3CD,
PLA2G7, PNPLA2, PRKAG2, PSAP,RAB5A,SGPL1, SLC27A1,UCP3
Molecular Transport 9.42E-05-
1.93E-02
ABCA12, ABCA2, ABHD5, ACSL1, ADFP, ADIPOR2,ALDH1A1, ARNTL,CD38, CEBPB,CETP, CTSS, DCI,DRD3, F3,
GHR,GOT2,HCK, HTT,INSIG1, LASS4, LPAR1,LPIN1, NEB, P2RY2,PCTP, PIK3CD, PLN, PNPLA2, PSAP,SGK1,
SLC27A1,TGFB2, TGFB3,TRPC3, UCN3, UCP3, UGP2,VWF
Small Molecule
Biochemistry
9.42E-05-2.6E-
02
ABCA12,ABCA2, ABHD5, ACSBG2, ACSL1,ADAM10,ADFP,ADIPOR2,ALDH1A1, ALDH6A1, AOX1,CD38,
CEBPB,CETP, CTSS, DCI, DRD3,FOXO3, GHR,GLS,GOT2, GRB10,HMGCL,HTT,INSIG1, LASS4, LPAR1,MTMR6,
MTMR7, NUDT3,PCTP, PDK4, PIK3CD,PLA2G7, PNPLA2,LPIN1, PHYH, PRKAG2,PRPS1, PRPS2, PSAP,RAB5A,
RPIA,SGPL1, SLC27A1, TGFB2,TGFB3, UCN3, UCP3,UGDH,UGP2
Carbohydrate
Metabolism
3.36E-04-2.6E-
02
ABHD5, ADAM10, ADIPOR2,ALDH2, CEBPB,CETP, FOXO3, GHR, HTT,IMPA2,MTMR6, MTMR7,PCTP, PDK4,
PIK3CD,PLA2G7, PRKAG2, PSAP,RAB5A, RPIA,SOCS3, TGFB2, TGFB3,UCN3, UCP3,UGDH, UGP2
Cell Death 3.36E-04 -
2.64E-02
ALDH1A1, ATPA1, BAG3, CD99, CDK2AP1, CEBPB, CTSS, DAPK1, DCN, FGF1, FGFR2, FOXO3, GHR, HTT,
IL15, MCL1, NEFH, PAX5, PKN2, RGS4, SGK1, SGPL1, SIAH1, SPARC, SRF, TGFB2, TGFB3, TPM3
The biological interpretation of expressional data was performed using Ingenuity Pathway Analysis 7.0 (IPA, Ingenuity Systems Inc., Redwood City, CA). The genes
included in the analysis were shown to be differential between F and L and/or between G+ and G- by either microarray or real-time RT-PCR. Genes are
presented in alphabetical order for each category. The genes over expressed in muscles with high (F or G+) and low glycogen content (L and G-) are in bold and
normal characters, respectively. Genes in italic were differentially regulated between models (F vs. L or G+ vs. G-).
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real-time RT-PCR in both models (G+/G- and F/L)
(Table 3). The level of 18S rRNA was chosen as refer-
ence and confirmed to be invariable. The expression
levels (normalized to 18S) of genes were compared
between G+ and G- and between F and L (n = 8, same
individuals used for microarray analyses) for each of the
16 genes selected. Ratios of gene expression determined
by real-time RT-PCR were compared to ratios obtained
using microarray analysis (Table 3). Over expression in
G+ compared to G- was clearly confirmed for CEBPB
and RGS2 (p ≤ 0.05), and suggested for FOXO3 as simi-
lar fold-changes reached significance in the microarray
analysis but not with real-time RT-PCR. Under expres-
sion was confirmed for LPAR1, PDK4, RPS6 and SRF
(p ≤ 0.05 or p ≤ 0.10), and suggested for PPP1R2B and
UCP3, as similar fold-changes were observed in micro-
array and RT-PCR studies. None of the differences sug-
gested between F and L chickens by the microarray
study could be statistically confirmed by RT-PCR.
Slightly higher expression of UGDH (p ≤ 0.10) and
lower expression of SRF (p ≤ 0.05) were suggested in F
compared to L chickens. It is of note that the genes
showed completely different variations between F and L
and between G+ and G-. None of the 3 genes over
expressed in G+ compared to G- (CEBPB, RGS2,
FOXO3) differed between F and L chickens. Similarly,
LPAR1 and RPS6, which were under expressed in G+
compared to G-, did not differ between F and L. By
contrast to what was observed when comparing G+ to
G-, PDK4 was over expressed in F compared to L, sug-
gesting an inverse relationship between muscle glycogen
and PDK4 expression in the two models. The observa-
tion of higher expression of ABHD5 in G+ compared to
G- on microarray prompted real-time RT-PCR measure-
ments in F and L. While the differential expression
between G+ and G- was not confirmed, significantly
higher expression was observed in F compared to L
chickens (p ≤ 0.05). The biological interpretation of the
real-time RT-PCR findings highlighted a gene network
involved in several molecular and cellular functions,
including lipid and carbohydrate metabolism, molecular
transport, small molecule biochemistry, and cell mor-
phology (Figure 1).
Differential analysis of candidate genes
The transcript expression of 14 genes (PRKAA1,
PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, and
Table 3 Difference in mRNA levels between Fat (F) and Lean (L) and between G+ and G- muscles for genes chosen for
quantification by real-time RT-PCR
Symbol Name G+/G- F/L
Microarray qRT-PCR Microarray qRT-PCR
Genes screened out from the microarray analyses
ABHD5 Abhydrolase domain containing 5 1.367* 0.997 NS 1.527*
ACSL1 Acyl-CoA synthetase long-chain family member 1 1.391* 0.994 NS 0.765
CEBPB CCAAT/enhancer binding protein (C/EBP), beta 1.491* 3.266** NS 0.828
ETFA Electron-transfer-flavoprotein, alpha polypeptide 0.719* 1.036 0.896* 0.896
FOXO3 Forkhead box O3 1.329* 1.400 NS 1.146
LPAR1 Lysophosphatidic acid receptor 1 0.511* 0.472* NS 1.243
PDK4 Pyruvate dehydrogenase kinase, isozyme 4 0.645* 0.397† ND 3.007†
PIK3CD Phosphoinositide-3-kinase, catalytic, delta polypeptide 1.768* 0.856 NS 1.613
PPP1R12B Protein phosphatase 1, regulatory (inhibitor) subunit 12B 0.758* 0.776 NS 1.103
RGS2 Regulator of G-protein signaling 2 1.778* 2.433* 1.454* 0.821
RPIA Ribose 5-phosphate isomerase A 1.380* 0.945 NS 1.352
RPS6 Ribosomal protein S6 0.611* 0.678† NS 1.014
SRF Serum response factor (c-fos serum response element-binding transcription factor) 0.562* 0.405* 0.734* 0.734
UCP3 Uncoupling protein 3 (mitochondrial, proton carrier) 0.641* 0.601 NS 0.731
UGDH UDP-glucose dehydrogenase NS 0.503† 1.441* 1.477
UGP2 UDP-glucose pyrophosphorylase 2 1.469* 0.873 NS 0.898
Candidate genes chosen for targeted analyses by real-time RT-PCR
§
PRKAB1 AMP-activated, beta 1 non-catalytic subunit ND 0.603† ND 1.315
PRKAG2 AMP-activated, gamma 2 non-catalytic subunit ND 0.517* ND 1.129
PHKD Phosphorylase kinase, delta ND 0.683* ND 1.115
For both microarray and real-time RT-PCR analyses, results are expressed as Fat to Lean and G+ to G- ratios of the expression gene.
NS = non-significant; ND = not determined. Statistical significance is indicated as follows: †p value < 0.1, *p value < 0.05, **p value < 0.01.
§ Only genes identified as differentially expressed in at least one model are presented in the Table.
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a1, a2, b1, b2, g1, g2, g3 subunits, respectively, GYS
encoding muscle glycogen synthase, GSK3 encoding gly-
cogen synthase kinase 3, PYG encoding glycogen phos-
phorylase, and PHKA PHKB, PHKD, and PHKG
encoding the glycogen phosphorylase kinase a, b, δ, g
subunits, respectively) directly involved in muscle glyco-
gen turnover was quantified by real-time RT-PCR.
Only 3 of them were significantly differentially
expressed between G+ and G- and their expression
ratios are presented in Table 3. None of the genes
assayed was significantly differentially expressed between
F and L chickens. The transcript levels of PRKAB1 and
PRKAG2, which encode the AMP-activated protein
kinase (AMPK) regulatory b1a n dg2 subunits, respec-
tively was lower in G+ than in G- muscles: The ratio of
G+/G- expression was 0.603 (p = 0.07) for PRKAB1 and
0.517 for PRKAG2 (p ≤ 0.05). The PHKD gene, which
encodes the δ subunit of phosphorylase kinase (also
referred as calmodulin), was also significantly down-
regulated (p ≤ 0.05) in G+ compared to G- muscles,
with a G+/G- expression ratio of 0.683.
Transcription factor analysis
Transcription factor analysis highlighted several interre-
lations between genes whose expression differential was
confirmed between G+ and G- animals by real-time RT-
PCR (Figure 2). Binding sites for the transcription factor
Figure 1 Network in which several genes identified as differential between Fat (F) and Lean (L) and/or G+ and G- muscles are
involved. The biological interpretation of expression data was performed using Ingenuity Pathway Analysis 7.0 (IPA, Ingenuity Systems Inc.,
Redwood City, CA). The genes included in the analyses were shown to be differential between F and L and/or G+ and G-. This gene network is
involved in several molecular and cellular functions including lipid and carbohydrate metabolism, molecular transport, small molecule
biochemistry, and cell morphology. The differential genes surrounded by a dashed line originated from the comparison between F and L birds,
and those surrounded by an unbroken line from the comparison between G+ and G- muscles originating from the F2 cross between the F and
L lines. The genes over-expressed in muscles with high (F or G+) and low glycogen content (L or G-) are circled in red and green, respectively.
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RGS2, UCP3, SRF, FOXO3. Similarly, promoters of
CEBPB, PRKAB1 and PDK4 possess the FOXO3 binding
site, and RPS6 and LPAR1 possess binding sites for SRF.
UGDH is under the control of PPARA (Peroxisome pro-
liferator-activated receptor alpha) that also activates
UCP3 and PDK4.
Discussion
Few studies have reported global gene expression sur-
veys in the chicken to date. Moreover, our study is the
first to relate global gene expression profiles to muscle
glycogen content and variations in meat quality. In
mammals, especially in cattle and the pig, several micro-
array studies have investigated global muscle gene
expression in relation to sensorial meat attributes such
as tenderness, juiciness, flavour and marbling, which are
not directly related to muscle glycogen content [15-17].
Recent analyses in the pig helped to link gene expres-
sion profiles to variations in meat water loss, this char-
acteristic being strongly related to variations in muscle
pH, but without considering glycogen variations in mus-
c l e[ 1 8 ] .T h et r a n s c r i p t sb e ing up-regulated with high
drip loss in the pig belong to groups of genes function-
ally categorized as genes of membrane proteins, signal
transduction, cell communication, response to stimulus,
and the cytoskeleton. Among genes down-regulated
with high drip loss, functional groups of oxidoreductase
activity, electron transport, and lipid metabolism were
identified.
The originality of our study lies in the models chosen
for microarray analyses. As already shown, there is a
positive relationship between body fatness and glycogen
content in breast muscle in the chicken [11-13]. Com-
paring divergently selected Fat and Lean chickens,
which also differ in muscle glycogen content [13], is
CEBPB
RPS6
UCP3
LPAR1
SRF
FOXO3
PDK4
PRKAG2
PRKAB1
RGS2
Transcription binding site match in promoter of the targeted gene
Connection annotated by Molecular Connections experts
Down-regulated in G+ compared to G- muscle
Up-regulated in G+ compared to G- muscle
UGDH
PPARA
CEBPB
RPS6
UCP3
LPAR1
SRF
FOXO3
PDK4
PRKAG2
PRKAB1
RGS2
Transcription binding site match in promoter of the targeted gene
Connection annotated by Molecular Connections experts
Down-regulated in G+ compared to G- muscle
Up-regulated in G+ compared to G- muscle
UGDH
PPARA
Figure 2 Summary of interactions between genes differentially expressed between G+ and G- muscles evidenced through a promoter
analysis. Genes highlighted in red and green were up- and down-regulated in G+ compared to G- muscle, respectively. Gene names are
indicated in capitals according to Gene Ontology. PPARA, Peroxisome proliferator-activated receptor alpha. Expression of PPARA was not
measured in the present study. See Table 3 for other gene names.
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variations in muscle glycogen directly related to varia-
tions in body fatness. It may however not be optimal for
distinguishing the mechanisms involved in the control
of adiposity and muscle glycogen metabolism. We there-
fore used chickens generated from a F2 cross between
the Fat and Lean lines. In this population, phenotypi-
cally extreme individuals with high and low muscle gly-
cogen content (+100% in G+ compared to G-) displayed
only limited differences in abdominal fat content (+30%
in G+ vs. G-). Being able to dissociate carcass fatness
and muscle glycogen content highlighted that, although
muscle glycogen metabolism and carcass adiposity are
under the control of shared regulation in chicken, they
also involve specific pathways. Working on F2 birds also
allowed comparison of birds with a more homogeneous
genetic background (due to two-generation crossing)
while specifically differing in muscle glycogen content.
Among the genes found to be expressed in chicken P.
major muscle, 197 and 254 transcripts were differentially
expressed between F and L and G+ and G-, respectively.
Notably, only 12 transcripts, corresponding to 7 known
genes, were recorded as differential in both models.
With the hypothesis that the G+/G- model was the
most powerful to identify genes controlling glycogen
metabolism and to rule out the possibility that some of
them could have been missed in the F/L comparison,
qRTPCR comparisons were conducted on both models
and focused on genes linked to glycogen and lipid meta-
bolism and differential between G+ and G-. The results
confirm that the differences are indeed specific of the G
+/G- model for most genes (Table 3) and even for the
genes showing a strong differential expression (CEBPB,
LPAR1, RGS2, RPS6) no difference was observed
between F and L. Moreover, the results also pointed out
that PDK4 and UGDH were inversely regulated in rela-
tion to glycogen content in G+/G- compared to F/L.
Similarly, we observed significant differences between G
+ and G- and not between F and L for three candidate
genes (PRKAB1, PRKAG2, PHKD). Altogether, the data
further supported that the comparison of extreme ani-
mals with high or low glycogen in the F2 population
was the most adapted to identify the mechanisms con-
trolling glycogen metabolism in chicken muscle. For this
reason we decided to further analyse 12 genes con-
firmed as differential between G+ and G-.
A bioinformatic analysis of the promoter sequences of
these genes indicated a transcriptional link between 11
of them and suggested a key role for the three transcrip-
tion factors, CEBPB, FOXO3, SRF as potential regulators
of several functional candidates affecting glycogen turn-
over in the muscle (Figure 2). Figure 3 attempts to sum-
marize how the differences observed at transcript level
could impact on glycogen metabolism. The lower
expression of UGDH (encoding UDP-glucose dehydro-
genase) in the G+ muscle is consistent with reduced
conversion of UDP-glucose into UDP-glucuronate, and
therefore higher use of glycogen synthesis. PHKD, that
encodes the δ subunit of the phosphorylase kinase com-
plex (PHK), was also expressed at lower levels in G+
muscle. This regulatory subunit (also referred to as cal-
modulin) contains the Ca
2+-binding site which allows
the activation of the phosphorylase kinase complex that
both activates glycogenolysis and inhibits glycogen
synthesis [19,20]. Its up-regulation in the G- muscle is
therefore consistent with increased activity of the PHK
complex and a reduced amount of glycogen in muscle.
The activity of the PHK complex is under the control of
both cAMP-dependent protein kinase (PKA) and AMP-
activated protein kinase (AMPK). The nuclear transcrip-
tion factor CCAAT/enhancer-binding protein beta
(CEBPB) and the regulator of G protein signalling 2
(RGS2) are involved in the control of the cellular cAMP
level and therefore in the activation of cAMP-dependent
protein kinase (PKA) [21-24]. PKA is known to suppress
inhibition of the gamma subunit of phosphorylase kinase
(PHK) and thereby activate the phosphorylase kinase
enzyme complex, which in turn activates glycogen phos-
phorylase and inhibits glycogen synthase [19,20]. Our
observations are therefore consistent with a potential
role of CEBPB and RGS2 in the regulation of glycogen
levels in chicken skeletal muscle, through the cAMP-
dependent PKA pathway. However, the LPAR1 gene
(lysophosphatidic acid receptor 1), which exerts a similar
effect on cAMP levels, showed different regulation,
being down-regulated in G+.
In the muscle of G+ chickens, we observed lower
expression of the gene encoding the regulatory g2s u b u -
nit of AMPK (PRKAG2). The AMP-dependence of the
AMPK complex is markedly affected by the identity of
the g isoform present, with g2-containing complexes
having a greater response to AMP than those containing
g1o rg3 [25]. Lower PRKAG2 mRNA levels in G+ mus-
cles could imply a lower response of the AMPK com-
plex to AMP, which in turn would be consistent with
greater amounts of glycogen in muscle. Although the
levels of AMPK activation were not measured in the
present study, a reduced level of AMPK activation was
previously reported in F compared to L chickens in con-
ditions where PRKAG2 mRNA levels were lower in F
than in L [13]. The PRKAB1 gene encoding the regula-
tory b1 subunit of AMPK was also expressed at lower
levels in G+ muscle, as previously described in [13]
when comparing F and L chickens. The AMPK b subu-
nit contains a glycogen-binding site which allows the
kinase to act as a glycogen sensor, AMPK activation
being inhibited by glycogen [26]. How the changed
expression of the b1 regulatory subunit is related to
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While in the former study [13], PRKAB1, PRKAG2 and
PHKD were relatively over expressed in the muscles of
L compared to F chickens, none of them were found to
be differentially expressed between F and L chickens in
the present study. One explanation could be that the
divergence in abdominal fatness was much more marked
(3 fold) between the Fat and Lean birds used in our pre-
vious study [13] than in those used in the present study
(2 fold), possibly related to the composition of the diet.
In fact, the birds used in the first experiment received a
diet with a higher crude protein level than those used in
the present study (19% instead of 17%) which might
explain the lower adiposity differential between Fat and
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Figure 3 Summary of changes observed in the expression of genes involved in the regulation of glycogen storage in G+ and
G- chickens and putative interactions between them. Genes highlighted in red and green were up- and down-regulated in G+ compared to
G- muscle, respectively. Genes in white boxes were not differentially expressed between G+ and G- muscles. Gene names are indicated in
capitals: PHKA, PHKB, PHKG, PHKD, Phosphorylase kinase, alpha, beta, gamma, delta subunit, respectively; PRKAA, PRKAB, PRKAG, AMP-activated
protein kinase, alpha, beta, gamma subunit, respectively; PKA, Protein kinase A; GYS, Glycogen synthase; PYG, Glycogen phosphorylase. See Table
3 for other gene names.
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marked phenotypic differences could be related to more
marked differences in gene expression.
A recent study [27] showed that AMPK activation
combined with fatty acid administration synergistically
induced pyruvate dehydrogenase kinase 4 (PDK4)
expression, and in turn decreased cellular glucose oxida-
tion. It can be expected that the preferential expression
of the g2 AMPK subunit (implying potentially greater
activation of the AMPK complex as discussed above) in
the G- muscles is consistent with the increased expres-
sion of PDK4 reported in our study. AMPK activation
also increases uncoupling protein 3 (UCP3) expression
in muscles in mammals [28,29]. In chicken muscle, sti-
mulation of AMPK is also associated with significant
over expression of the avian UCP, the ortholog gene of
mammalian UCP3 [30]. The relative down-regulation of
the AMPK g2 subunit was thus consistent with that
of UCP3 (or avUCP) reported concomitantly in G+
muscle. As already mentioned, PDK4 was not down-
regulated by higher glycogen content in the muscle of
the F line, but in contrast, up-regulated, suggesting a
strong interaction with lipid metabolism, which could
also result from the absence of regulation of AMPK sub-
units between F and L in the present study which con-
trasted with earlier results [13].
Several microarray studies conducted in genetically
modified mice reported very distinct global gene expres-
sion profiles between animals exhibiting high or low gly-
cogen content in muscle [31-33]. There are only a few
common genes between those highlighted in our study
and those demonstrated to be regulated in such models.
This could arise from the fact that our birds were much
less divergent in terms of glycogen content than the
transgenic mice used previously, and also from the fact
that different mechanisms may be involved. In mice, gly-
cogen content was altered by invalidation or overexpres-
sion of genes directly controlling glycogen content such
as GYS and PRKAG3. The study of Parker et al. (2006)
[31] comparing mice lacking [32] or accumulating [33]
glycogen in muscle, as a result of glycogen synthase
(GYS) inactivation or overexpression, revealed marked
differences in expression for a number of enzymes
involved in the regulation of glycogen metabolism.
Comparison of mutant and knockout mice for PRKAG3
showed that changes in the activity of the g3 subunit of
AMPK were accompanied by coordinated and reciprocal
regulation of carbohydrate and lipid metabolism [34].
Indeed, mutation 225Q (corresponding to the RN+ allele
gene identified in the pig [7]), which causes accumula-
tion of glycogen in muscle, was associated with a gene
expression profile suggesting increased glucose and lipid
uptake, oxidative capacity and glycogen synthesis, and
resistance of muscle to fatigue. Only slight disturbances
in gene expression were observed between G+ and G-
chickens, suggesting that the corresponding phenotypes
resulted from the additive effects of several genes on the
muscle glycogen in the chicken rather than a major
e f f e c to fas i n g l eg e n es u c ha st h eR Ng e n ei nt h ep i g
[7]. The present study highlighted changes in several
candidate genes directly involved in the control of glyco-
gen metabolism such as PHKD, PRKAB1 & G2 and
PDK4 and also in genes involved in cAMP signalling
such as CEBPB, RGS2 and LPAR1. These transcriptional
candidate genes warrant further study in larger popula-
tions to correlate their expression with muscle glycogen
levels, and to investigate the underlying mechanisms.
Conclusions
The aim of the study presented here was to identify can-
didate genes involved in the control of glycogen content
in muscle. Studying phenotypically extreme chickens for
muscle glycogen content generated from a F2 cross
population helped to distinguish mechanisms involved
in lipid and carbohydrate metabolism, which are highly
related in the chicken. Several genes, related to carbohy-
drate metabolism or not, were suggested as potentially
active in the regulation of muscle glycogen content and
hence meat quality in the chicken. A QTL search is in
progress on the F2 cross population used in the present
study that aims to identify chromosomal regions
involved in the control of phenotypes related to chicken
meat quality, including muscle glycogen content. This
should help to identify both functional and positional
genes that could be subsequently included in large scale
expression studies to validate the relationship between
variations in gene expression and meat quality. These
studies should together allow the identification of mole-
cular markers that could be used to select birds with
expected muscle and meat properties, and to optimize
rearing practices via the study of gene regulation.
Methods
Animals, Rearing and Slaughtering conditions
Chickens were bred at INRA, UE1295 Pôle d’Expéri-
mentation Avicole de Tours, F-37380 Nouzilly in accor-
dance with European Union Guidelines for animal care
and under authorization 37-112 delivered to C. Berri by
the French Ministry of Agriculture.
The experimental Fat (F) and Lean (L) lines were gen-
erated from a composite meat-type strain of six different
origins. F and L lines were divergently selected for
abdominal fatness at 9 weeks of age over 7 generations,
resulting in a wide difference in carcass fatness [13]. In
the first experiment, 8 female chickens from each line
were selected from a total of 72 broilers (36 F and 36 L)
for further gene expression profile analyses. Within the
overall population, the breast muscle glycolytic potential
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(female > male, p < 0.01). Although no line/sex interac-
tion was found, only females were included in microar-
ray analysis to rule out any sex effect.
In the second experiment, the gene expression profiles
of individuals generated from the F2 population pro-
duced from a 2 generation intercross between the foun-
der F and L lines were compared. The F2 population
consists of about 600 individuals produced from the
cross of 5 F1 sires and 50 F1 dams. The 8 female chick-
ens exhibiting the lowest (G-) and the 8 exhibiting the
highest (G+) muscle glycogen content were used for
microarray analysis.
In both experimental schemes, the birds were reared
up to 9 weeks of age under regular conditions in a con-
ventional poultry house. At 9 weeks of age and after
7 hours of feed withdrawal, the birds were slaughtered
a n dp r o c e s s e da tt h ee x p e r i m e n t a lp o u l t r yu n i ta s
already described [2].
Phenotypic traits
Live body weight (BW), abdominal fat percentage and
breast yield were measured in addition to ultimate meat
pH, meat colour at 24 h post-slaughter, and drip loss
after two days of storage at 2°C, as already described [2].
Meat colour was measured by the CIELAB trichromatic
system as lightness (L*), redness (a*), and yellowness
(b*) values. The glycolytic potential (GP) was deter-
mined according to Dalrymple and Hamm [35], from
1 g of muscle tissue collected 15 min. post-slaughter
and immediately frozen in liquid nitrogen and calculated
as described in Sibut et al. [13].
RNA isolation
Total RNA was extracted from P. major muscle samples
rapidly frozen in liquid nitrogen after death using the
Qiagen RNeasy Midi Kit (Qiagen, Courtaboeuf, France),
according to the manufacturer’s instructions. Concentra-
tion and quality of extracted RNA were assessed using a
Nanodrop 1000 spectrophotometer (Nanodrop Technol-
ogy
®, Wilmington, DE) and a 2100 Bioanalyser (Agilent
Technologies, Massy, France), respectively.
Oligo design and array spotting
The Chicken 20 K Array was obtained from CRB
GADIE (INRA Jouy en Josas; http://crb-gadie.inra.fr).
The array design has been published in Gene Expression
Omnibus with the platform name GPL8199 [36]. The
Chicken 20K Oligo set was produced from 20,460 oligo-
nucleotides (60 to 75 nucleotides) designed using the
OligoArray 2.0 software against the chicken ENSEMBL
transcripts. The transcripts were selected from the
chicken genome draft available in December 2004 and
extensive matching of the UMIST and DT40 full length
EST’s with the TIGR clusters (http://chick.umist.ac.uk/).
Oligos from a 20K set were arrayed by Operon in 384-
well V-bottomed plates (Genetix). Each well contained
1 nmol of oligo. They were resuspended in water on
Staccato RapidPlate (Caliper). Spotting was performed
on glass slides (Corning, Ultragaps), with 48 Stealth 3
Microspotting pins on Chipwriter (Virtek), with control
of humidity (45-50%). After the print run was com-
pleted, oligo plates were covered with seals and deep
frozen at -20°C in a protected environment. The arrays
produced contained exactly the 20,460 oligonucleotides
from the original set, 442 buffer spots and 218 unusable
oligos (internal control from Opéron). On this array
batch, three were used for batch quality control valida-
tion: arrays were controlled by SybrGreen to check the
presence, intensity and overall shape of the spots and
the lack of signal in negative controls (buffer). A lot is
considered validated when 95% of observed signals
appear where an oligo is expected and if no signal
appears in the negative controls.
Annotation
Because the 20 K oligonucleotide set was defined in 2004
from heterogeneous data sources, the quality of the pre-
viously designed oligonucleotides was checked, compar-
ing them with the chromosomes of the 2.1 Washington
University assembly of the chicken sequence genome
[37]. The comparison was made using NCBI Blast with a
75% similarity threshold over 50 base pairs. The tran-
scripts were then retrieved for each high scoring pair
(HSP) corresponding to the location using the Ensembl
API (version 3 Ensembl 52). An oligonucleotide had to
be in a single gene (even if it was spanning 2 exons) to be
selected for further analyses. The corresponding annota-
tions were then retrieved from Ensembl using the Blast
HSP coordinates. Among the 20,460 gene-oligonucleo-
tides, 12,907 were identified as aligning with a single cod-
ing region in the chicken genome sequence (Version 3.2,
February 2009). As an Ensembl gene name and/or a GO
biological process term for only 32% of the 12,907 oligo
subset were retrieved, it was decided to rely on human
orthologs (according to the “one to one” criteria of
ENSEMBL annotation) which could be identified for 94%
of the 12,907 oligonucleotides, making it possible to
r e t r i e v eH G N C - H U G Og e n es y m b o l sf o rt h em a j o r i t yo f
them (75% of 94% of 12,907). The annotations obtained
by a bioinformatics procedure developed by SIGENAE
(INRA) are available on the web site: http://www.sigenae.
org [37].
Microarray procedure
mRNA labelling and hybridization
Fifty μg of each RNA sample were reverse-transcribed
and labelled with Alexa fluorescent-dyes using the
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(Invitrogen, Cergy-Pontoise, France), according to the
manufacturer’s instructions. A dye-switch procedure was
used by labelling F and L or G+ and G- individuals
alternately with Alexa 555 green dye and Alexa 647 red
dye (Molecular Probes, Invitrogen). After purification,
the labelled cDNA samples were quantified using the
NanoDrop in order to define the dye concentration and
the Frequency Of Incorporation (FOI) which was calcu-
lated as follows: FOI (Dye/1000 bases) = Dye (pmol)/
cDNA (ng) * 324.5 (pg/mol). According to the manufac-
turer, the optimal FOI should be between 20 and 50
dye-labelled nucleotides per 1000 nucleotides. The slides
were dynamically hybridized at 42°C for 16 h in 30 to
40 μl of buffer (PRONTO!, Corning, Life Sciences ) con-
taining 30 to 50 pmoles of each dye using the Slide-
Booster (Olympus Advalytix, Germany). Microarrays
were then washed with the AdvaWash (Olympus Adva-
lytix, Germany). We finally obtained an initial subset of
8 microarrays for each paired sample from F and L
chickens, and a second subset of 8 microarrays for each
paired sample from G+ and G-. In all cases, hybridiza-
tions were performed with a balanced block design (i.e.
half of the samples were labelled with Alexa 555 and
the other half with Alexa 647 for each condition). The
fluorescence ratio for each gene reflected the relative
abundance of the mRNA of interest of either F to L or
G+ to G- chickens.
Data acquisition
Detection of the fluorescence signals was performed
with a laser scanner (GenePix 4000B from Axon Instru-
ment, CA) keeping a constant PMT gain for each chan-
nel. Image analysis was performed with GenepixPro 6.0
software (Axon instruments, Inc., Union City, CA) [38].
Raw data files for each array containing all measured
values were stored in GenePix files and analysed with
the Anapuce 2.0 package (http://cran.r-project.org/web/
packages/anapuce/index.html) [39] developed in R lan-
guage. This package contains functions for the normali-
zation and the analysis of data.
Filtering and data normalization
For the normalization step, data were first filtered
according to the genepix flag criterion automatically
performed by GenepixPro 6.0 [38]. Spots were then dis-
carded in cases of lack of fluorescence homogeneity or
overlapping with a contiguous spot. The homogeneity of
the background and the fluorescence intensity was sys-
tematically checked on each microarray by the boxplot
and image plot functions of the R package.
The Alexa 647/Alexa 555 ratio used for analysis was
expressed as the log2 of the ratio of median pixel inten-
sity of the two red and green channels. Log2 median
ratio values were then normalized on each individual
array according to the hypothesis that the majority of
gene expressions do not differ between two samples.
Normalization was performed by global loess and block
effect correction via subtraction of the median per block
using the Anapuce 2.0 package [39].
Data deposition
The microarray data were deposited in the Gene Expres-
sion Omnibus (GEO) public repository http://www.ncbi.
nlm.nih.gov/geo The accession numbers for the series
are GSE17428 and GSE17445, and the sample series can
be retrieved with accession numbers GSM434777 to
GSM434784 and GSM435103 to GSM435110. The sam-
ple series for each microarray contains the raw data
(median signal) of each Alexa637 and Alexa555 channel
as well as the normalized data (log2 (Alexa637/Alexa555
ratio)).
Data analysis
To identify genes differentially expressed between F and
L and G+ and G- chickens we used the DiffAnalysis
functions of Anapuce 2.0 under the R statistical environ-
ment. Because of the high test numbers, corresponding
to the number of genes tested, the raw p value of each
gene was adjusted according to the Benjamini-Hochberg
method controlling the false discovery rate [40]. Differ-
ence in gene expression was judged significant if its
adjusted p value was p < 0.05.
Real-time RT-PCR assay
Five μg of each RNA sample were reverse-transcribed
using RNase H
- MMLV reverse transcriptase (Super-
script II, Invitrogen, Illkirch, France) and random pri-
mers (Promega, Charbonnières les Bains, France).
A 1/50 or 1/100 dilution of RT reaction, corresponding
to 50 or 100 ng RNA equivalent, was then used for real-
time quantitative PCR. cDNA samples were mixed with
the SYBR Green I qPCR Master Mix Plus (Eurogentec,
Angers, France) and specific reverse and forward pri-
mers. Primers are described in additional file 4 for genes
originating from the microarray analyses and in [13] for
candidate genes (PRKAA1, PRKAA2, PRKAB1,
PRKAB2, PRKAG1, PRKAG2, and PRKAG3 encoding
the AMP-activated protein kinase a1, a2, b1, b2, g1, g2,
g3 subunits, respectively, GYS encoding muscle glycogen
synthase, GSK3 coding glycogen synthase kinase 3, PYG
encoding glycogen phosphorylase, PHKA, PHKB, PHKD,
and PHKG encoding the glycogen phosphorylase kinase
a, b, δ, g subunits, respectively). The level of 18 S ribo-
somal RNA (18S) chosen as a reference was determined
with the TaqMan Universal qPCR Master Mix Kit and a
pre-developed Taqman assay reagent (Applied Biosys-
tems). Reaction mixtures were incubated in an ABI
PRISM 7000 apparatus (Applied Biosystems, Courta-
boeuf, France) programmed to conduct one cycle (95°C
for 10 min) and 40 cycles (15 s at 95°C and 1 min at
60°C, 62°C or 64°C according to the gene) [13]. For
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gramme was then performed to check the presence of a
single product with a specific melting temperature.
Amplification products were checked by electrophoresis
and further sequenced. PCR runs for each sample were
performed in triplicate. Each PCR run included a no-
template control and triplicates of control, i.e. a pool of
12 cDNA samples (i.e. 6 for high and 6 for low GP con-
dition). The calculation of absolute mRNA levels was
based on the PCR efficacy and the threshold cycle (CT)
deviation of an unknown cDNA versus the control
cDNA according to the equation proposed by Pfaffl [41]
and as already described [42]. For all genes under study
and for 18S, the amplification rates were in the range of
99% to 100% and could be considered as equal to 1. For
the same sample, the gene expression level could thus
be normalized in relation to the 18S expression level.
Functional annotation and promoter analysis
The biological interpretation of expressional data was
performed using Ingenuity Pathway Analysis 7.0 (IPA,
Ingenuity Systems Inc., Redwood City, CA) and Gene
Ontology (GO, http://www.geneontology.org/). The
genes included in the analyses were shown to be differ-
entially expressed (microarray or real-time RT-PCR)
between F and L, G+ and G- or both. For the genes
validated as differentially expressed between G+ and G-,
analysis of promoters was performed by using the
MatInspector and Eldorado applications of Genomatix
(http://www.genomatix.de) [43,44].
Additional material
Additional file 1: Genes differentially expressed between Fat and
Lean chickens. Results were expressed as the Fat to Lean ratio of the
gene expression. The p value of each gene was adjusted according to
the Benjamini-Hochberg method controlling the False Discovery Rate
[40]. Difference in gene expression was considered significant if its
adjusted p value was p < 0.05.
Additional file 2: Genes differentially expressed between the G+
and G- chickens generated from the F2FL population. Results were
expressed as G+ to G- ratio of the gene expression. The p value of each
gene was corrected according to the Benjamini-Hochberg method
controlling the False Discovery Rate [40]. Difference in gene expression
was considered significant if its adjusted p value was p < 0.05.
Additional file 3: List of the common genes that were differentially
expressed in the two models (Fat vs. Lean chickens and G+ vs. G-
chickens generated from the F2FL population).
Additional file 4: Selected real-time RT-PCR primer sequences and
accession numbers.
Abbreviations
a*: redness; ABHD5: Abhydrolase domain containing 5; ACSL1: Acyl-CoA
synthetase long-chain family family member 1; AMPK: AMP-activated protein
kinase; b*: yellowness; BW: Body Weight; CEBPB: CCAAT/enhancer binding
protein beta; DFD: Dry, Firm and Dry; LPAR1: Endothelial differentiation
lysophosphatidic acid G-protein-coupled receptor 2; ETFA: Electron transfer
flavoprotein subunit alpha mitochondrial precursor; FDR: False Discovery
Rate; GP: Glycolytic Potential; FOI: Frequency of Incorporation; FOXO3:
Forkhead protein; GSK3: Glycogen Synthase Kinase 3; GYS: Glycogen
Synthase; HGNC: HUGO Gene Nomenclature Committee; HSP: high scoring
pair; IPA: Ingenuity Pathway Analysis; L*: lightness; PDK4: Pyruvate
dehydrogenase kinase isozyme 4; PHKA: Glycogen Phosphorylase Kinase
subunit alpha; PHKB: Glycogen Phosphorylase Kinase subunit beta; PHKD:
Glycogen Phosphorylase Kinase subunit delta; PHKG: Glycogen
Phosphorylase Kinase subunit gamma; pHu: ultimate pH; PIK3CD:
Phosphoinositide-3-kinase catalytic delta polypepetide; PMT: PhotoMultiplier
Tube; PPP1R12B: Myosin light chain phosphatase small subunit major
isoform; PRKAA1: AMP-activated protein kinase subunit alpha 1; PRKAA2:
AMP-activated protein kinase subunit alpha 2; PRKAB1: AMP-activated
protein kinase subunit beta 1; PRKAB2: AMP-activated protein kinase subunit
beta 2; PRKAG1: AMP-activated protein kinase subunit gamma 1; PRKAG2:
AMP-activated protein kinase subunit gamma 2; PRKAG3: AMP-activated
protein kinase subunit gamma 3; PYG: Glycogen Phosphorylase; real-time RT-
PCR: real-time Reverse Transcription-Polymerase Chain Reaction; SRF: Serum
response factor; RGS2: Regulator of G-protein signalling 2; RPIA: Ribose 5-
phosphate isomerase A; RPS6: Ribosomal protein; UCP3: Uncoupling protein
3 (mitochondrial proton carrier); UGDH: UDP-glucose dehydrogenase; UGP2:
UDP-glucose pyrophosphorylase 2.
Acknowledgements
This research program was supported by a grant from the ANR-Genanimal
Program (France). VS was supported by a grant from CIFRE (France). The
authors thank the staff of the breeding facilities (INRA, UE1295 Pôle
d’Expérimentation Avicole de Tours, Nouzilly, France) and laboratory (INRA,
UR83 Recherches Avicoles, Nouzilly, France) for their technical assistance. The
authors also thank Aurélien Brionne for his technical help in the
development of hybridization procedures and in the automation of
annotation, Philippe Bardou from SIGENAE for his help in the depositing of
data in the public repository Gene Expression Omnibus, CRB-GADIE for
supplying the microarrays, and Dr Sandrine Lagarrigue for annotation
analyses.
Author details
1INRA UR83 Recherches Avicoles, Institut National de la Recherche
Agronomique, F-37380 Nouzilly, France.
2Institut Technique de l’Aviculture,
Centre INRA de Tours, F-37380 Nouzilly, France.
3INRA Centre de Ressources
Biologiques des Animaux Domestiques et d’Intérêt Economique, Institut
National de la Recherche Agronomique, F-78352 Jouy en Josas Cedex,
France.
Authors’ contributions
VS carried out the gene expression, annotation and statistical analyses and
drafted the manuscript. CHA supervised the statistical analyses. CB
supervised the study. CB, MJD, and EBD participated in the design of the
study, the phenotype data collection and helped to draft the manuscript.
SM contributed to the creation of microarrays. All authors read and
approved the final manuscript.
Received: 28 June 2010 Accepted: 16 February 2011
Published: 16 February 2011
References
1. Mead GC: Meat Quality and consumer requirements. In Poultry Meat
Processing and Quality. Edited by: GC Mead. CRC Press, Boca Raton, FL
(USA), Woodhead Publishing Ltd, Cambridge, England; 2004:1-18.
2. Berri C, Le Bihan-Duval E, Debut M, Santé-Lhoutellier V, Baéza E, Gigaud V,
Jégo Y, Duclos MJ: Consequence of muscle hypertrophy on
characteristics of Pectoralis major muscle and breast meat quality of
broiler chickens. J. Anim. Sci 2007, 85:2005-2011.
3. Le Bihan-Duval E, Debut M, Berri C, Sellier N, Santé-Lhoutellier V, Jégo Y,
Beaumont C: Chicken meat quality: genetic variability and relationship
with growth and muscle characteristics. BMC Genetics 2008, 9:53.
4. Barbut S: Problem of pale soft exudative meat in broiler chickens. Br.
Poult. Sci 1997, 38(4):335-358.
5. Allen CD, Russell SM, Fletcher DL: The relationship of broiler breast meat
color and pH to shelf-life and odor development. Poult. Sci 1997,
76(7):1042-1046.
Sibut et al. BMC Genomics 2011, 12:112
http://www.biomedcentral.com/1471-2164/12/112
Page 12 of 136. Ciobanu D, Bastiaansen J, Malek M, Helm J, Woollard J, Plastow G,
Rothschild M: Evidence for new alleles in the protein kinase adenosine
monophosphate-activated gamma(3)-subunit gene associated with low
glycogen content in pig skeletal muscle and improved meat quality.
Genetics 2001, 159(3):1151-1162.
7. Milan D, Jeon JT, Looft C, Amarger V, Robic A, Thelander M, Rogel-
Gaillard C, Paul S, Iannuccelli N, Rask L, Ronne H, Lundström K, Reinsch N,
Gellin J, Kalm E, Le Roy P, Chardon P, Andersson L: A mutation in PRKAG3
associated with excess glycogen content in pig skeletal muscle. Science
2000, 288:1248-1251.
8. Andersson L: Identification and characterization of AMPK γ 3 mutations
in the pig. Biochem. Soc. Trans 2003, 31:232-235.
9. Barnes BR, Marklund S, Steiler TL, Walter M, Hjälm G, Amarger V,
Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M,
Stapleton D, Zierath JR, Andersson L: The 5’-AMP-activated protein kinase
gamma3 isoform has a key role in carbohydrate and lipid metabolism in
glycolytic skeletal muscle. J Biol Chem 2004, 279(37):38441-7.
10. Costford SR, Kavaslar N, Ahituv N, Chaudhry SN, Schackwitz WS, Dent R,
Pennacchio LA, McPherson R, Harper ME: Gain-of-function R225W
mutation in human AMPK gamma(3) causing increased glycogen and
decreased triglyceride in skeletal muscle. PLoS One 2007, 2(9):e903.
11. Berri C, Wacrenier N, Millet N, Le Bihan-Duval E: Effect of selection for
improved body composition on muscle and meat characteristics of
broilers from experimental and commercial lines. Poult. Sci 2001,
80:833-838.
12. Le Bihan-Duval E, Berri C, Baéza E, Millet N, Beaumont C: Estimation of the
genetic parameters of meat characteristics and of their genetic
correlations with growth and body composition in an experimental
broiler line. Poult. Sci 2001, 80:839-843.
13. Sibut V, Le Bihan-Duval E, Tesseraud S, Godet E, Bordeau T, Cailleau-
Audouin E, Chartrin P, Duclos MJ, Berri C: Adenosine monophosphate-
activated protein kinase involved in variations of glycogen and breast
meat quality between lean and fat chickens muscle. J. Anim. Sci 2008,
86:2888-2896.
14. Leclercq B, Blum JC, Boyer JP: Selecting broilers for low and high
abdominal fat: Initial observations. Br. Poult. Sci 1980, 21:107-113.
15. Lobjois V, Liaubet L, SanCristobal M, Glenisson J, Feve K, Rallieres J, Le
Roy P, Milan D, Cherel P, Hatey F: A muscle transcriptome analysis
identifies positional candidate genes for a complex trait in pig. Animal
Genetics 2008, 39(2):47-162.
16. Wang YH, Byrne KA, Reverter A, Harper GS, Taniguchi M, McWilliam SM,
Mannen H, Oyama K, Lehnert SA: Transcriptional profiling of skeletal
muscle tissue from two breeds of cattle. Mammalian Genome 2005,
16:201-210.
17. Bernard C, Cassar-Malek I, Le Cunff M, Dubroeucq H, Renand G,
Hocquette JF: New indicators of beef sensory quality revealed by
expression of specific genes. J. Agric. Food Chem 2007, 55(13):5229-37.
18. Ponsuksili S, Murani E, Phatsara C, Jonas E, Walz C, Schwerin M,
Schellander K, Wimmers K: Expression profiling of muscle reveals
transcripts differentially expressed in muscle that affect water-holding
capacity of pork. J Agric. Food Chem 2008, 56(21):10311-7.
19. Ferrer JC, Favre C, Gomis RR, Fernandez-Novella JM, Garcia-Rocha M, de la
Iglesia N, Cid E, Guinovart JJ: Control of glycogen deposition. FEBS Letters
2003, 546:127-132.
20. Soderling TR, Srivastava AK, Bass MA, Khatra BS: Phosphorylation and
inactivation of glycogen synthase by phosphorylase kinase. Proc. Natl.
Acad. Sci. USA 1979, 76(6):2536-40.
21. Croniger CM, Millward C, Yang J, Kawai Y, Arinze IJ, Liu S, Harada-Shiba M,
Chakravarty K, Friedman JE, Poli V, Hanson RW: Mice with a deletion in the
gene for CCAAT/enhancer-binding protein beta have an attenuated
response to cAMP and impaired carbohydrate metabolism. J. Biol. Chem
2001, 276(1):629-38.
22. Kehrl JH, Sinnarajah S: RGS2: a multifunctional regulator of G-protein
signaling. Int. J. Biochem. Cell Biol 2002, 34(5):432-438.
23. Anliker B, Chun J: Cell surface receptors in lysophospholipid signaling.
Semin. Cell. Dev. Biol 2004, 15:457-46534.
24. Yoshida A, Ueda H: Activation of Gi1 by lysophosphatidic acid receptor
without ligand in the baculovirus expression system. Biochem. Biophys.
Res. Commun 1999, 259:78-84.
25. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D: Characterization of
AMP-activated protein kinase gamma-subunit isoforms and their rôle in
AMP binding. Biochem J 2000, 3:659-669.
26. McBride A, Ghilagaber S, Nikolaev A, Hardie DG: The glycogen-binding
domain on the AMPK beta subunit allows the kinase to act as a
glycogen sensor. Cell Metab 2009, 9(1):23-34.
27. Houten SM, Chegary M, Te Brinke H, Wijnen WJ, Glatz JF, Luiken JJ,
Wijburg FA, Wanders RJ: Pyruvate dehydrogenase kinase 4 expression is
synergistically induced by AMP-activated protein kinase and fatty acids.
Cell. Mol. Life Sci 2009, 66(7):1283-94.
28. Stoppani J, Hildebrandt AL, Sakamoto K, Cameron-Smith D, Goodyear LJ,
Neufer PD: AMP-activated protein kinase activates transcription of the
UCP3 and HKII genes in rat skeletal muscle. Am J Physiol Endocrinol Metab
2002, 283(6):E1239-48.
29. Putman CT, Kiricsi M, Pearcey J, MacLean IM, Bamford JA, Murdoch GK,
Dixon WT, Pette D: AMPK activation increases uncoupling protein-3
expression and mitochondrial enzyme activities in rat muscle without
fibre type transitions. J Physiol 2000, 551(Pt 1):169-78.
30. Joubert R, Métayer Coustard S, Swennenb Q, Sibut V, Crochet S, Cailleau-
Audouin E, Buyse J, Decuypere E, Wrutniak-Cabello C, Cabello G,
Tesseraud S, Collin A: The beta-adrenergic system is involved in the
regulation of the expression of avian uncoupling protein in the chicken.
Domest. Anim. Endocrinol 2009, 38(2):115-125.
31. Parker GE, Pederson BA, Obayashi M, Schroeder JM, Harris RA, Roach PJ:
Gene expression profiling of mice with genetically modified muscle
glycogen content. Biochem J 2006, 395(1):137-45.
32. Pederson BA, Chen HY, Schroeder JM, Shou WN, DePaoli-Roach AA,
Roach PJ: Abnormal cardiac development in the absence of heart
glycogen. Mol. Cell. Biol 2004, 24(16):7179-7187.
33. Manchester J, Skurat AV, Roach P, Hauschka SD, Lawrence JC: Increased
glycogen accumulation in transgenic mice overexpressing glycogen
synthase in skeletal muscle. PNAS 1996, 93(20):10707-10711.
34. Nilsson EC, Long YC, Martinsson S, Glund S, Garcia-Roves P, Svensson LT,
Andersson L, Zierath JR, Mahlapuu M: Opposite transcriptional regulation
in skeletal muscle of AMP-activated protein kinase gamma3 R225Q
transgenic versus knock-out mice. J. Biol. Chem 2006, 281(11):244-52.
35. Dalrymple RH, Hamm R: A method for extraction of glycogen and
metabolites from a single muscle sample. J. Food Technol 1973, 8:439-444.
36. Gene expression omnibus. [http://www.ncbi.nlm.nih.gov/projects/geo/].
37. Klopp C, Moreews F, Aubry M, Lagarrigue S: Contribution to the
annotations of the Chicken 20 K oligo microarray of ARKGenomics. Plant
& Animal Genomes XVI Conference: January 12-16 2008.
38. Genepix User’s guide and tutorial. [http://www.soe.ucsc.edu/classes/
bme210/Spring07/GenePix_Pro_6.0_Manual_RevL.pdf].
39. Anapuce 2.0 download and tutorial. [http://www.agroparistech.fr/mia/
doku.php?id=productions:logiciels#anapuce2.0].
40. Benjamini Y, Hocheberg Y: Controlling the false discovery rate - a
practical and powerful approach to multiple testing. Journal of the royal
statistical society seriesB- Methodological 1995, 57(1):289-300.
41. Pfaffl MW: A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 2001, 29:2003-2007.
42. Guernec A, Berri C, Chevalier B, Wacrenier-Ceré N, Le Bihan-Duval E,
Duclos MJ: Muscle development, insulin-like growth factor-I and
myostatin mRNA levels in chickens selected for increased breast muscle
yield. Growth. Horm. IGF Res 2003, 13:8-18.
43. Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and
MatInspector: new fast end versatile tools for detection of consensus
matches in nucleotide sequence data. Nucleic Acid Res 1995, 23:4878-84.
44. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A,
Frisch M, Bayerlein M, Werner T: MatInspector and beyond: promoter
analysis based on transcription factor binding sites. Bioinformatics 2005,
21:2933-42.
doi:10.1186/1471-2164-12-112
Cite this article as: Sibut et al.: Identification of differentially expressed
genes in chickens differing in muscle glycogen content and meat
quality. BMC Genomics 2011 12:112.
Sibut et al. BMC Genomics 2011, 12:112
http://www.biomedcentral.com/1471-2164/12/112
Page 13 of 13